Objective: Expression of adhesion molecules on endothelial cells and subsequent monocyte adhesion are initial events in the development of atherosclerosis. The purpose of this study was to investigate the role of apurinic/apyrmidinic endonuclease1/redox factor-1 (APE1/ref-1) in the interaction of monocytes with vascular endothelial cells. 
Introduction
The development of an atherosclerotic lesion requires a complex interplay between mononuclear cells, endothelia, vascular smooth muscle cells, growth factors, and cytokines. Monocyte rolling and adhesion to the vascular endothelial lining and subsequent diapedesis are not only the first steps, but also seem to be crucial events in the pathological process [1] . Expression of cell adhesion molecules, such as vascular cell adhesion molecule-1 (VCAM-1), on endothelial cells represents one of earliest pathological changes in inflammatory diseases, such as atherosclerosis [2] . As the phenotype of endothelial cells is subject to change by oxidative stress, reactive oxygen species (ROS), such as superoxide ions, are implicated in the pathogenesis of cardiovascular disorders [3] .
Among the endogenous mechanisms that repair oxidative DNA damage is the ubiquitously expressed apurinic/ apyrimidinic endonuclease1/redox factor-1 (APE1/ref-1), APE1/ref-1 is a protein with dual function [4] . It is an essential endonuclease in the base excision repair pathway of oxidatively damaged DNA, as well as having reducing properties that promote the binding of redox-sensitive transcription factors such as activator protein-1 to their cognate DNA sequences [5, 6] . In addition to its nuclear functions, an extra-nuclear role for APE1/ref-1 in the regulation of endothelial oxidative stress has been uncovered. APE1/ref-1 suppresses oxidative stress through modulation of cytoplasmic rac1-regulated ROS generation [7, 8] . This action of APE1/ref-1 and its reported effect on endothelial nitric oxide (NO) levels [9] , suggests a possible protective role for APE1/ref-1 in inflammatory vascular disorders.
Vascular APE1/ref-1 is upregulated in atherosclerosis and animal models of hypertension [10] . However, the functional role of APE1/ref-1 in the early pathogenesis of inflammatory vascular disorders such as atherosclerosis is not known. We hypothesized that APE1/ref-1 expression serves to suppress endothelial cell adhesion molecule expression and consequent monocyte adhesion to the endothelium.
Methods

Cell culture and reagent
Human umbilical vein endothelial cells (HUVECs) were purchased from Clonetics (Cambrex Bio Science, MD, USA) and were grown and maintained in endothelial growth medium. Cells were used between passages 3 and 6. U937 cell lines were obtained from American type culture collection (Manassas, VA, USA). Anti-VCAM-1 and anti-APE1/ref-1 were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-phospho-p38, anti-phopho-eNOS, and anti-p38 were from Cell Signaling technology (Beverly, MA, USA). Anti-Cu/Zn SOD and anti-Mn SOD were from Stressgen (Victoria, BC Canada). HRP-labeled anti-rabbit and anti-mouse antibodies were from Amersham (Buckinghamshire, UK). Human TNF-a, l-nitroarginine methyl ester, dihydroethidine were purchased from Sigma (St. Louis, MO, USA).
Western blot analysis
Twenty-four to 48 h after infection with adenoviruses, expression and phosphorylation of proteins (50 Ag) was determined by Western blotting as described previously [9] . Immunoreactivity was detected with an enhanced chemiluminescence (ECL) kit (Amersham Pharmacia Biotech).
Adenoviral transfections
Adenoviruses encoding h-galactosidase (Adhgal), fulllength APE1/ref-1 (AdAPE1/ref-1), were generated by homologous recombination in human embryonic kidney 293 cells, and have been described previously [9] . HUVECs were infected with 200 multiplicity of infection (MOI; particle forming units per cell) of specified adenovirus for 18 h. The virus was removed and cells incubated for another 24 h.
Detection of superoxide production
Intracellular superoxide was detected by using the superoxide-sensitive fluorophore dihydroethidine (DHE). For detection of DHE fluorescence, cells were grown in chamber slides (2 Â 10 5 cells/well) (Nalgen Nunc International). Cells were rinsed three times with 3 ml of Krebs-HEPES buffer and then incubated in 10 AM DHE for 20 min at 37 -C in Krebs -HEPES buffer. DHE was then washed from the cells to avoid absorption of any extracellular oxyethidium formed by autooxidation of DHE, and cells were imaged using a confocal microscope. 7 cells/ml) with 1 AM BCECF-AM in RPMI-1640 medium for 30 min at 37 -C and 5% CO 2 . HUVECs were seeded in 24-well plates to reach confluent monolayers and incubated with Adhgal (as a control) or AdAPE1/ref-1 for 24 h in EGM-2 medium. Human recombinant TNF-a was added to appropriate wells (15 ng/ml) for 18 h before addition of labeled monocytes. Monocyte adhesion was quantified by measuring fluorescence with excitation (485 nm) and emission (535 nm) filters. Wells containing HUVEC only without U937 cells were used as blanks.
Statistical analysis
Values are expressed as the mean T SEM. Statistical evaluation was performed using Student t test, with p < 0.05 considered significant.
Results
Overexpression of APE1/ref-1 suppressed monocyte adhesion in the TNF-a-stimulated HUVECs
To explore whether APE1/ref-1 regulates monocyte adhesion, we first examined adhesion of U937 cells to TNF-a-stimulated HUVECs. As shown in (Fig. 2B). 
Nitric oxide mediates APE1/ref-1-induced suppression of VCAM-1 expression
NO has been demonstrated to attenuate VCAM-1 expression in endothelial cells [11, 12] . We have recently shown that APE1/rEF-1 increases endothelial NO production via H-ras/Akt/eNOS pathway in endothelial cells [9] . Therefore, we investigated whether nitric oxide is involved in APE1/ref-1 mediated suppression of VCAM-1. As shown in 
Overexpression of APE1/ref-1 reduces superoxide anion production in TNF-a-treated HUVECs
It is well known that oxidative stress is an important intracellular signaling mediator for VCAM-1 expression in the endothelial cells. Therefore, we also investigated whether overexpression of APE1/ref-1 suppressed superoxide production induced by TNF-a. APE1/ref-1 overexpression significantly suppressed TNF-a-induced increase in intracellular superoxide without affecting basal superoxide levels in HUVECs (Fig. 4A) . Densitometric data was plotted in Fig. 4B . We also investigated whether the suppression of superoxide production by APE1/ref-1 is mediated by upregulation of superoxide dismutases (SOD) (Fig. 4C) 
Discussion
APE1/ref-1 has been implicated in protection against cell death resulting from oxidative stimuli [13, 14] . Depletion of APE1/ref-1 renders cells more sensitive to hypoxia [15] , and a decrease in APE1/ref-1 expression is associated with apoptosis in ischemic neuronal tissue [16] . In addition, APE1/ref-1 is capable of initiating the repair of apurinic/ Expression of adhesion molecules accelerates the adhesion and migration of monocytes toward sites of inflammation in response to a variety of stimuli. Particularly, cellular adhesion molecules are an important components in atherosclerosis and the response to vascular injury [17] . Histological studies demonstrate increased endothelial expression of VCAM-1 and intracellular adhesion molecule-1 (ICAM-1) in developing and established atherosclerotic lesions [18, 19] . Early atherosclerotic events and the initiation of lesion formation appear particularly dependent on VCAM-1 [20] . Furthermore, Dansky and colleagues' findings in Vcam1 D4D/D4D Apoe À/À mice [21] suggested a major role for VCAM-1 in the initiation of atherosclerotic process. This likely reflects an important function for VCAM-1 in recruitment of monocytes to the arterial intima.
We previously reported that APE1/ref-1 regulates endothelial nitric oxide production and vascular tone via the upregulation of H-ras/phosphoinositide-3 kinase/Akt kinase/ eNOS pathway [9] . Interestingly, its nitric oxide donors inhibit cytokine-induced VCAM-1 expression in the endothelial cells [11] . In the present study, APE1/ref-1-stimulated suppression of VCAM-1 was inhibited by the NOS inhibitor l-NAME, suggesting that increased nitric oxide It is also noteworthy that activation of VCAM-1 expression is redox-sensitive, with compounds with antioxidant properties inhibiting VCAM-1 expression [22] . Our results suggest that APE1/ref-1 suppresses superoxide production in TNF-a in endothelial cells and are consistent with previous observations [7] . Therefore, the effect of APE1/ref-1 on VCAM-1 expression may also be partly dependent on this mechanism of action. It should be noted however, that APE1/ref-1 did not up-regulate antioxidant enzymes such as SOD. On the contrary, it decreased the expression of Mn SOD which was up-regulated by superoxide. This result suggests that APE1/ref-1 decreases ROS generation via an SOD-independent mechanism. Previously, it was reported that APE1/ref-1 overexpression suppressed oxidative stress via inhibiting the rac1 GTPase [8] . Therefore, attenuation of superoxide production induced by APE1/ref-1 might be due to inhibition of TNF-a-induced rac1 activation.
Stimuli that result in oxidative stress employ a number of cellular ROS generating systems. Among these is the NADPH oxidase regulated by the ubiquitous small GTPase rac1. The functional significance of this oxidase is evident by the fact that rac1-regulates the production of ROS in a variety of cell types in response to a many oxidative stimuli such as TNF-a [23] and hypoxia/reoxygenation [24] .
In mammalian cells, MAPKs are strongly activated by growth factors, environmental stresses and inflammatory cytokines [25] . TNF-a can activate MAPKs in the signaling pathway leading to expression of several cytokines [26] . In the present study, p38 MAPK was activated by TNF-a. However, this activation of MAPK was partially blocked by the overexpression of APE1/ref-1 in endothelial cells. This finding suggests that inhibition of p38 MAPK might be due to APE1/ref-1-mediated decrease of ROS production.
In summary, this report shows that APE1/ref-1 has an important function in suppressing monocyte adhesion and VCAM-1, through a NOS-dependent mechanism, and by reducing intracellular oxidative stress in endothelial cells. Considering the biological functions of APE1/ref-1 presented in these studies, it is tempting to speculate that endogenous vascular APE1/ref-1 might serve an antiinflammatory role.
